MAPS Canada Podcast

Making Meaning of Psychedelic Experiences with Shauntal! In Episode 6 of The Medicine Within, host Osheen Dayal sits down with registered clinical counsellor and MAPS Canada Development Lead, Shauntal Padda, to explore the deeply important role of integration in psychedelic healing. Together, they speak about: Why integration is where healing continues Somatic work, breath, and reconnecting with the body Neuroplasticity, intention setting, and mindfulness Community, safety, and culturally grounded healing Learning to trust yourself through discomfort and transformation This conversation is a reminder that psychedelic healing is not just about the journey itself — it is about how we carry those insights into our everyday lives. Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

In this episode of the MAPS Canada Podcast, host Matt Hamel speaks with filmmaker Scott Paul Wright about his documentary The Next Chapter, an intimate and deeply human exploration of adults over the age of 55 who are turning to psychedelic-assisted therapy as a pathway to healing, meaning-making, and renewal. The film follows individuals navigating depression, anxiety, grief, trauma, and existential questions later in life, often after conventional treatments have not provided sufficient relief. Through their stories, The Next Chapter highlights both the challenges and the possibilities of psychedelic-assisted therapy, while centering the importance of integration, human connection, and hope. Scott also shares his own personal journey into this work, including his experience with psilocybin at age 68, and how that experience shaped his decision to create the film. What emerges is a reflection on vulnerability, transformation, and the shared human search for meaning. The upcoming world premiere of The Next Chapter takes place on June 18, 2026 at The Royal Cinema in Toronto, followed by a live Q&A panel featuring the filmmaker alongside leading clinicians, researchers, and voices in Canada’s psychedelic medicine community, including Dr. Joshua Rosenblat and Dr. Blake Pearson. The event is designed as a community gathering and conversation, bridging lived experience with clinical and research perspectives at a time when psychedelic-assisted therapy is rapidly entering the public discourse in Canada. For more information about the documentary and how you can attend, visit https://thenextchapterfilm.com/ Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

In this episode of the MAPS Canada Podcast, host Matt Hamel speaks with Dr. Linda Carlson and Dr. Ron Shore about CAN-PACT (the Canadian Network for Psychedelic-Assisted Cancer Therapy), a groundbreaking national initiative exploring the role of psilocybin-assisted therapy for people living with advanced cancer. Dr. Carlson and Dr. Shore discuss the emotional and existential challenges many cancer patients face, including anxiety, uncertainty, grief, demoralization, and fear surrounding death and dying. They explain how CAN-PACT is building a cross-Canada network of researchers, clinicians, patient partners, and educators to investigate how psychedelic-assisted therapy may help address these deeply human experiences. The conversation explores: • Existential distress and demoralization in cancer care • Group-based psilocybin-assisted therapy • Mindfulness and psychedelic-assisted therapy • The role of spirituality, meaning, and connection • Training clinicians for future psychedelic-assisted care • The future of psychedelic-assisted therapy in Canada The episode also examines how CAN-PACT hopes to create sustainable, evidence-based models that could eventually be integrated into mainstream cancer care across Canada. Learn more about CAN-PACT: https://canpact.ca Watch the MAPS Canada Research Room presentation featuring CAN-PACT: https://www.youtube.com/watch?v=lA3MGuxkiC0 Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

In this episode of the MAPS Canada Podcast, host Rielle Capler speaks with Steve Allgood about his experience navigating a terminal brain cancer diagnosis and the unexpected role psychedelics played in helping him confront fear, depression, and existential distress. Steve shares the emotional reality of being diagnosed with terminal brain cancer just days before his wedding, the difficult process of radiation treatment, and the psychological toll of living under the belief that his life would soon end. The conversation explores his search for hope through alternative approaches to care, including high-dose cannabis and psilocybin mushrooms, and how these experiences gradually transformed his relationship to illness, suffering, and meaning. The discussion also highlights the importance of emotional support, psychedelic safety, and reducing stigma around end-of-life care and alternative therapies. Through Steve’s deeply personal story, the episode offers insight into the growing conversation surrounding psychedelics, mental health, and quality of life for individuals facing serious illness. Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

In this episode of The Medicine Within, host Osheen Dayal is in conversation with Ryan Schebek, registered clinical counsellor and ketamine-assisted therapist, exploring what it means to navigate a ketamine-assisted journey. From set and setting to surrender, dissociation, and integration, this episode breaks down what ketamine can — and can’t — offer, and why preparation and ethical care matter just as much as the experience itself. Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Are psychedelics the "miracle cure" often portrayed in the media, or is the reality more nuanced? In this episode of the MAPS Canada podcast, host Osheen Dayal is joined by Jagpaul Kaur Deol — a neuropharmacologist, researcher and MAPS Canada board member — to discuss the essential science of psychedelic safety. We move beyond the hype to look at how these substances actually interact with the body and mind, and why a "one-size-fits-all" approach doesn’t work in this field. Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

In this episode of the MAPS Canada Podcast, host Warren Jane speaks with MAPS Canada’s Executive Director Dr. Rielle Capler about the role of public education in the rapidly evolving field of psychedelics. Dr. Capler outlines how MAPS Canada is working to make complex research, policy developments, and therapeutic frameworks more accessible to a wide range of audiences. From research presentations and webinars to podcasts and online courses, the conversation explores how different educational formats are designed to meet people where they are. The discussion also highlights the importance of community engagement, psychedelic safety and risk reduction, and diverse perspectives in shaping a responsible approach to psychedelic education, offering insight into how informed public discourse can support the future of the field. Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

What if addiction isn't the problem but a response to something deeper? In this episode, Dr. Pamela Kryskow joins host Kyle Sittek-Lumsden to explore the role of psychedelic-assisted therapy in the treatment of substance use disorders. Drawing on her clinical experience, Dr. Kryskow discusses how addiction is increasingly understood as a response to trauma, emotional pain, and disconnection, rather than a moral failing. The conversation highlights how addressing root causes rather than symptoms alone can lead to meaningful and lasting change. The discussion also examines current treatment approaches in Canada, including ketamine, psilocybin, and MDMA-assisted therapies, as well as the importance of preparation, integration, and community support. Dr. Kryskow reflects on the evolving landscape of psychedelic medicine, ongoing barriers to access, and what a more effective, patient-centered system of care could look like in the future. Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

In Episode 3 of Our Medicine Within Series, host Osheen Dayal is in conversation with Raman Samra, a clinical counsellor and art therapist with over a decade of experience working in the correctional system and private practice, now serving as a psychedelic-assisted therapist in clinical trials. Topics of discussion include: Why intention matters When and how to set it How to prepare the day before The importance of mindset, space, and context Finding the right guide, therapist, or sitter Safety, support, and ethical facilitation Preparation isn’t optional — it’s part of the medicine. Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

In this episode of the MAPS Canada Podcast, host Rielle Capler sits down with Francine Douglas to explore the theme of wellness and connection through a deeply personal, cultural, and systemic lens. Drawing from her experience as a First Nations woman, counsellor, and co-founder of Sacred Circle Wellness, Francine reflects on the medicine wheel and the interconnection of physical, emotional, mental, and spiritual health. She shares how sacred medicines offered a reminder to a return to balance, self-care, cultural practice, and belonging. This conversation moves beyond individual wellness into collective healing — examining how relationship, reciprocity, and cultural remembrance are essential foundations for true wellbeing. Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: https://www.x.com/mapscanada https://www.instagram.com/mapscanada https://www.facebook.com/MAPSCanada MAPSCanada #Psychedelic #Research #Medicine #Therapy #Breathwork #PsychedelicTherapy #TraumaHealing #MedicineWithin

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: https://www.x.com/mapscanada

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: / mapscanada / mapscanada / mapscanada MAPSCanada #Psychedelic #Research #Medicine #Therapy

Support MAPS Canada Podcast

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: https://twitter.com/mapscanada https://www.instagram.com/mapscanada/ https://www.facebook.com/MAPSCanada/ MAPSCanada #Psychedelic #Research #Medicine #Therapy

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: https://twitter.com/mapscanada https://www.instagram.com/mapscanada/ https://www.facebook.com/MAPSCanada/ MAPSCanada #Psychedelic #Research #Medicine #Therapy

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: https://twitter.com/mapscanada https://www.instagram.com/mapscanada/ https://www.facebook.com/MAPSCanada/ MAPSCanada #Psychedelic #Research #Medicine #Therapy

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: https://twitter.com/mapscanada https://www.instagram.com/mapscanada/ https://www.facebook.com/MAPSCanada/ MAPSCanada #Psychedelic #Research #Medicine #Therapy

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: https://twitter.com/mapscanada https://www.instagram.com/mapscanada/ https://www.facebook.com/MAPSCanada/ MAPSCanada #Psychedelic #Research #Medicine #Therapy #Psychedelics #RacialTrauma #MentalHealth #SafeSpaces #TherapistTraining

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: https://twitter.com/mapscanada https://www.instagram.com/mapscanada/ https://www.facebook.com/MAPSCanada/ MAPSCanada #Psychedelic #Research #Medicine #Therapy #Psychedelics #RacialTrauma #MentalHealth #SafeSpaces #TherapistTraining

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: / mapscanada / mapscanada / mapscanada MAPSCanada #Psychedelic #Research #Medicine #Therapy #drugchecking #harmreduction #testbeforeyouingest

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ MAPSCanada #Psychedelic #Research #Medicine #Therapy #OsheenInterviews #psychedelictreatment #psychedelictherapy #mapscanada #research #books

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: / mapscanada / mapscanada / mapscanada

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: / mapscanada / mapscanada / mapscanada MAPSCanada #Psychedelic #Research #Medicine #Therapy #HarmReduction #CannabisResearch #PublicHealth #BCCSU #SubstanceUse #GenderEquity #HousingCrisis #AddictionScience #CannabisScience #HarmReduction #OverdosePrevention #OpioidCrisis #DTES #BCCSU #SubstanceUseResearch #DrugPolicy #MAPSCanada #PsychedelicScience #PublicHealthCanada

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: / mapscanada / mapscanada / mapscanada MAPSCanada #Psychedelic #Research #Medicine #Therapy #PsychedelicSafety #MAPSCanadaPod #PsychedelicHealing #HarmReduction #Podcast

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy. Learn More at https://mapscanada.org/about/ MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/ Many ways to engage, join our community: / mapscanada / mapscanada / mapscanada

"Isn't microdosing just placebo effect??" You may have heard this before but is it true? Dr. Zachary Walsh, a leading clinical psychologist and researcher, explores the therapeutic potential of psychedelics in this episode, focusing on psilocybin-assisted psychotherapy for opioid titration and his involvement in the Microdose.me study. He explains the distinction between cannabis, used for symptom relief, and psychedelics and discusses the controversial link between cannabis and psychosis, emphasizing the need for further research. Join us as he shares insights on the evolving role of clinicians in supporting patients interested in microdosing and the challenges of integrating psychedelic medicine into healthcare! Donate to MAPS Canada at https://mapscanada.org/donate/

Have you humbled yourself to your elders? These women elders of the psychedelic underground are spiritual warriors-fearless in their journeys to the shamanic realms. Rachel Harris, PhD, is the author of "Swimming in the Sacred: Wisdom from the Psychedelic Underground" and "Listening to Ayahuasca." A psychologist who has been in private practice for 40 years, she spent 10 years in an academic research department where she published more than 40 scientific studies in peer-reviewed journals and received a National Institutes of Health New Investigator’s Award. Rachel splits her time between an island in Maine and the San Francisco Bay Area. Visit her online at http://www.swimminginthesacred.com Donate to MAPS Canada at https://mapscanada.org/donate/

Michael Phillip is the creator and host of Third Eye Drops, a media vessel dedicated to philosophy, psychology, spirituality, meaning, and adventure (both physical and mental). Michael is a writer, podcast host, speaker, community-builder, and wonder junkie holding a B.A. in Journalism. Check it out at https://thirdeyedrops.com/ And consider donating to MAPS Canada at https://mapscanada.org/donate/

Don Lattin is a veteran religion journalist and award-winning author of several books on psychedelics including The Harvard Psychedelic Club and his latest book God on Psychedelics. He was a speaker at Psychedelic Science 2023, the world biggest ever conference on psychedelics, and he has been closely following the movement from it's beginnings. In this podcast, hear Don Lattin's perspective on the rise of psychedelic churches, the NYU-John Hopkins study on religious clergy members experience after two psilocybin sessions Find more about Don Lattin here: www.donlattin.com More information on Don Lattin's latest book God on Psychedelics: https://apocryphilepress.com/book/psychedelics/

David Bronner is the CEO (Cosmic Engagement Officer) of Dr. Bronners as well as a board member of MAPS and a long-time activist and leader in the psychedelic, hemp and organic-fair trade movements.

Listen to this interview with Rick Doblin on new results from the MAPS Phase III clinical trials for MDMA assisted therapy, the upcoming biggest psychedelic conference in the world ever—Psychedelic Science 2023—and stories of getting banned from the U.S for life. Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS) founded in 1986. MAPS is a nonprofit organization that provides public education, research and policy reform towards the legal, responsible and evidence–based use of psychedelics. Rick has dedicated 50 years of his life towards this mission and MAPS now leads the way towards creating legal context for the beneficial uses of psychedelics on an international scale. We are MAPS Canada, a sister organization to the U.S. based MAPS. MAPS needs MDMA therapists! Learn more about becoming an MDMA therapist here: https://mapsbcorp.com/training/ Check out the biggest psychedelic conference ever, Psychedelic Science 2023: https://psychedelicscience.org/

In this episode Dennis McKenna joins MAPS Canada in discussing Ayahuasca tourism, the McKenna Academy of Natural Philosophy, Biognosis, the future of the psychedelic movement and the counter-force to the movement—the "war on consciousness". Dennis McKenna has conducted research in ethnopharmacology for over 40 years. He is a founding board member of the Heffter Research Institute and was a key investigator on the Hoasca Project, the first biomedical investigation of ayahuasca. He was part of the original Scientific Strategy Team at Shaman Pharmaceuticals in the early 90s. He is the younger brother of Terence McKenna. From 2000 to 2017, he taught courses on Ethnopharmacology and Plants in Human affairs as an adjunct Assistant Professor in the Center for Spirituality and Healing at the University of Minnesota. In the spring of 2019, in collaboration with colleagues in Canada and the US, he incorporated a new non-profit, the McKenna Academy of Natural Philosophy. In collaboration with colleagues he organized two landmark conferences in 2017 and 2022, the Ethnopharmacologic Search for Psychoactive Drugs (see ESPD50.com and ESPD55.com) He emigrated to Canada in the spring of 2019 together with his wife Sheila, and now resides in Abbotsford B.C. Learn more about the McKenna Academy, Biognosis and how you can support, here: https://mckenna.academy/

🇺🇦 Meet the researcher conducting research to bring MDMA assisted therapy to Ukrainian refugees abroad and ultimately, to the countless victims of the Ukraine War. In this MAPS Canada Podcast episode, Luc Briedé-Cooper and Sabrina Ramkellawan sit down with Dr. Olga Chernoloz a Ukrainian researcher based in Canada. Become part of the psychedelic movement by donating at: https://mapscanada.org/donate/ Dr. Chernoloz has extensive experience in research of psychoactive compounds for mental health and neurological applications. She is a scientific advisor to Psychedelics Studies Research Group at University of Toronto and has held a number of roles in clinical trial management, drug development, biotech, and pharmaceutics.

This is the first episode of the (relaunched) MAPS Canada Podcast featuring MAPS Canada's own board member Kayla Breelove Carter discussing trauma, race and psychedelic therapy. Kayla Breelove Carter works with individuals and organizations to increase their awareness and understanding of trauma, racial trauma, and adverse childhood experiences. With over ten years of clinical experience, Kayla specializes as well in nutritional psychology and psychedelic assisted therapy. As a clinical supervisor for those seeking licensing in New Brunswick and Nova Scotia, Kayla also dedicates her time in supporting graduate students through Breelove’s weekly free counselling clinic and community counselling program, where individuals seeking counselling therapy can engage in one on one mental health counselling for free. Become part of the psychedelic movement by donating at https://mapscanada.org/donate/

This episode concludes Season 1 of the MAPS Canada Podcast. What better way to end our first season than with a very special guest, Dr. Erika Dyck. Erika is a Canadian Historian, Professor of History at the University of Saskatchewan, a Canadian Research Chair, and an editor with the Chacruna Institute for Psychedelic Plant Medicines. Erika joins us for an interview with Jaipreet Mattu to discuss her 20 years of research on Canada’s past with psychedelic psychiatry, the growing awareness of the role women played in the development of psychedelic therapy, Indigenous use of psychedelic plants and protecting their cultural rights, and lastly, the global future of psychedelic plant medicine. Erika’s research focuses mainly on the history of medicine, health and social justice, and of course, the history of psychedelics in psychiatry. She’s taught classes on the history of medicine and psychiatry, social justice and gender equality in medicine, and eugenics. She’s also written on women’s health in other aspects of Canadian health care. More recently, Erika’s research focuses on women in the history of psychedelic psychiatry. She highlights the importance of thinking about the intersections of gender in psychedelics and incorporating new voices and discussions about gender considerations in the development of psychedelic therapy. Links: Chachruna Institute for Psychedelic Plant Medicines Graphic Novel—"Wonder Drug: LSD in the Land of Living Skies” MAPS Special Bulletin—Women and Psychedelics Women on Psychedelics Société Psychédélique Française - Webinar ‘Gender, Women and Psychedelics’ MAPS Canada is a registered non-profit; we rely on the generosity of our supporters to fund our life-changing research. Please visit mapscanada.org/donate to become a monthly donor or to make a one-time donation today! Feedback? Feel free to email us at: [email protected] This episode was produced and edited by Brendon Campbell. Original music and audio engineering by Andrew Illmann.

For this bonus interview, we’re joined by Canadian lawyer turned historian and journalist, Ross Crockford. Ross was the editor of Monday Magazine, an alternative weekly paper in Victoria, BC and has over two decades of experience researching Canada’s past, present, and future with psychedelics. It was during his work as an editor that he discovered the work done by Dr. Abram Hoffer; he actually went on to interview Hoffer himself as well as several of his patients, along with many other early psychedelic pioneers. We’ll be back on July 19th, with an episode featuring Canadian Historian, Dr. Erika Dyck. Erika joins us to discuss her research on Canada’s history with psychedelics, the history of women and psychedelics, and some of the exciting projects she is collaborating on with individuals from around the world, alongside the Chacruna Institute for Psychedelic Plant Medicines. This episode was produced and edited by Brendon Campbell. Original music and audio engineering by Andrew Illmann. MAPS Canada is a registered non-profit; we rely on the generosity of our supporters to fund our life-changing research. Please visit mapscanada.org/donate to become a monthly donor or to make a one-time donation today! Feedback? Feel free to email us at: [email protected]